Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 7/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.32 |
| ▸ | GLS2 | Q9UI32 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4408803 | 1.00 | ACHE (0.35) | ACHEBACE1PTPN1ALOX5PTGS2 | |
| SCHEMBL6331072 | 0.82 | — | — | |
| SCHEMBL19031882 | 0.81 | STAT3 (0.30) | — | |
| SCHEMBL234448 | 0.76 | ACHE (0.40) | ACHEBACE1PTPN1ALOX5PTGS2 | |
| SCHEMBL4650397 | 0.72 | ACHE (0.35) | ACHEBACE1PTPN1ALOX5PTGS2 | |
| SCHEMBL1548523 | 0.72 | ACHE (0.35) | ACHEBACE1PTPN1ALOX5PTGS2 | |
| SCHEMBL4650395 | 0.72 | ACHE (0.35) | ACHEBACE1PTPN1ALOX5PTGS2 | |
| SCHEMBL6544586 | 0.71 | ACHE (0.47) | ACHEBACE1PTPN1ALOX5PTGS2 | |
| SCHEMBL7247559 | 0.70 | LCK (0.30) | — | |
| SCHEMBL6413040 | 0.69 | ACHE (0.50) | ACHEBACE1PTPN1ALOX5PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090182337-A1 | Antimicrobial Coatings | TYCO HEALTHCARE GROUP LP | 2009-07-16 | — | — | US | disclosed |
| US-20090182337-A1 | Antimicrobial Coatings | TYCO HEALTHCARE GROUP LP | 2009-07-16 | — | — | US | disclosed |
| US-20090182337-A1 | Antimicrobial Coatings | TYCO HEALTHCARE GROUP LP | 2009-07-16 | — | — | US | disclosed |
| EP-2024113-A1 | ANTIMICROBIAL COATINGS | Tyco Healthcare Group LP (US) | 2009-02-18 | — | — | EP | disclosed |
| WO-2007133782-A1 | ANTIMICROBIAL COATINGS | TYCO HEALTHCARE GROUP LP (US) | 2007-11-22 | — | — | WO | disclosed |
| WO-2007133782-A1 | ANTIMICROBIAL COATINGS | TYCO HEALTHCARE GROUP LP (US) | 2007-11-22 | — | — | WO | disclosed |
| WO-2005005598-A2 | B. ANTHRACIS LUXS AND FURANONE INHIBITION OF A1-2 QUORUM SENSING | NEW YORK UNIVERSITY (US) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090182337-A1 | Antimicrobial Coatings | CUTA, GSDMD, GPX4 | ACHE 3945/4885BACE1 3213/4885PTPN1 1426/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.